CLINICAL_TRIALS
trial_result
· 2019-06-27
Clinical Trial Update: Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome [Phase 3]
Summary
A Phase 3 trial assessing efficacy and safety of Eutropin in Prader-Willi Syndrome has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LG Life Sciences | Conditions: Prader-Willi Syndrome | Phase 3 | Status: COMPLETED